|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.06 CNY | -1.31% |
|
-3.10% | -18.08% |
Sichuan Goldstone Asia Pharmaceutical Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 479.43 million compared to CNY 535.54 million a year ago. Net income was CNY 82.2 million compared to CNY 74.13 million a year ago.
Basic earnings per share from continuing operations was CNY 0.2046 compared to CNY 0.1845 a year ago. Diluted earnings per share from continuing operations was CNY 0.2046 compared to CNY 0.1845 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.08% | 510M | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +18.99% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -8.33% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.22% | 5.52B |
SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC. 